ST Pharm Co. Ltd. | Ownership
Companies that own ST Pharm Co. Ltd.
The Vanguard Group, Inc.
203,734
1.09%
127
0%
07/31/2018
Norges Bank Investment Management
153,372
0.82%
-4,728
0%
12/31/2017
BlackRock Advisors (UK) Ltd.
148,336
0.8%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
44,016
0.24%
0
0%
03/31/2018
Baillie Gifford & Co.
24,671
0.13%
0
0%
10/31/2017
BC Investment Management Corp.
18,413
0.1%
18,413
0%
03/31/2017
Mirae Asset Global Investments Co., Ltd.
16,462
0.09%
4,420
0%
04/30/2018
Charles Schwab Investment Management, Inc.
7,409
0.04%
0
0%
09/06/2018
State Street Global Advisors Ltd.
1,159
0.01%
0
0%
09/05/2018
Samsung Asset Management Co., Ltd.
822
0%
-99,787
0%
07/06/2018
| Address |
#802, Siheunggongdan 1-Na
Siheung-si GY 15086
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.stpharm.co.kr |
| Updated |
09/14/2018 |
| ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic Active Pharmaceutical Ingredients (APIs), Fine Chemical, and Bio. The New Drug CMO business offers services such as process optimization, documentation support, and validation. |
